Jacobi Capital Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Jacobi Capital Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-6,393	Closed	-$362K	–	1092
2019 Q3	$362K	Sell	6,393 -607	-9%	-$34.9K	0.07%	216
2019 Q2	$421K	Sell	7,000 -187	-3%	-$11.5K	0.09%	195
2019 Q1	$468K	Buy	7,187 +106	+1%	+$6.97K	0.12%	127
2018 Q4	$441K	Sell	7,081 -857	-11%	-$57.8K	0.12%	128
2018 Q3	$583K	Buy	7,938 +247	+3%	+$17.7K	0.16%	89
2018 Q2	$517K	Buy	7,691 +13	+0.2%	+$836	0.15%	92
2018 Q1	$465K	Buy	7,678 +437	+6%	+$28.8K	0.14%	88
2017 Q4	$477K	Buy	7,241 +574	+9%	+$36.8K	0.15%	87
2017 Q3	$444K	Buy	6,667 +1,095	+20%	+$69.2K	0.15%	82
2017 Q2	$349K	Buy	+5,572	New	+$334K	0.14%	78

Other funds holding PJP

BCI

Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Jacobi Capital Management's PJP Position: Q4 2019 in Review

Jacobi Capital Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q4 2019, closing a stake of 6,393 shares — an estimated $362K sold.

Jacobi Capital Management first reported a position in PJP in Q2 2017 and held it in 10 quarters. The position peaked at $583K in Q3 2018. 93 funds tracked by Wall St. Rank hold PJP as of Q4 2019.

Jacobi Capital Management reported no remaining Invesco Pharmaceuticals ETF position as of Q4 2019 after selling out during the quarter.
Jacobi Capital Management sold 6,393 Invesco Pharmaceuticals ETF shares in Q4 2019, an estimated $362K.
Jacobi Capital Management first reported a position in Invesco Pharmaceuticals ETF in Q2 2017 and held it in 10 quarters.
Jacobi Capital Management's Invesco Pharmaceuticals ETF position peaked at $583K in Q3 2018.
93 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2019.

Based on Jacobi Capital Management's 13F filing for Q4 2019, filed 3 Feb 2020.